Babylon Health

πŸ”΄Shutdown / Dead

Babylon Health was a UK telehealth and AI symptom-checker company that went public via SPAC in 2021 at a $4.2B valuation. Its 'AI doctor' chatbot drew regulatory scrutiny from the UK MHRA over accuracy claims. After delisting from the NYSE and an attempted private rescue in 2023, the US subsidiary filed Chapter 7 bankruptcy in August 2023 and the UK operation went into administration. The brand and apps are gone.

Reason for Shutdown

US subsidiary filed Chapter 7 in Aug 2023; UK operation entered administration. All consumer apps were withdrawn from app stores by end of 2023.

πŸ’΅ Pricing & access

Pricing model
Not documented
Starting at
No longer sold
Official site
Visit Babylon Health β†’

🩺 Health Signals

No checks have been run on this tool yet.

πŸ“… Timeline

2021-10-21

Goes public via SPAC at $4.2B valuation

https://www.reuters.com/business/healthcare-pharmaceuticals/babylon-health-go-public-via-merger-with-alkuri-2021-10-21/

2023-06-08

Delisted from NYSE after rescue talks fail

https://www.reuters.com/business/healthcare-pharmaceuticals/babylon-health-delisted-nyse-2023-06-08/

2023-08-09

US subsidiary files Chapter 7 bankruptcy

https://www.beckerspayer.com/payer/babylon-files-chapter-7-bankruptcy.html

πŸ”„ Alternatives to Babylon Health

πŸ“° Related Articles

Why Babylon Health Failed (Case Study)Β·2 min read

Why Babylon Health Failed: A Case Study in AI Startup Pitfalls

Babylon Health, once valued at $4.2 billion, embarked on an ambitious journey to revolutionize healthcare with AI. However, the company’s trajectory took a downturn, culminating in its permanent shutdown in August 2023. This case study examines the factors that led to the demise of the prominent UK telehealth and AI symptom-checker.

Top Alternatives to Babylon HealthΒ·4 min read

Babylon Health Alternatives: Top AI Chatbots for Health Information in 2026

Babylon Health, once a prominent telehealth and AI symptom-checker, has shut down. For those seeking similar AI-powered health information tools, robust alternatives like Perplexity AI and ChatGPT offer advanced conversational AI capabilities.

Best AI Tools Like Babylon HealthΒ·23 min read

8 Best Tools Like Babylon Health in 2026 (AI Health Picks)

Babylon Health β€” the London-founded digital-first primary care and AI symptom-checker company that listed on the NYSE at a $4.2 billion SPAC valuation in 2021 β€” collapsed into administration in August 2023, taking its consumer app and NHS GP at Hand relationship with it and leaving millions of former patients, NHS commissioners, insurers, and clinics searching for a replacement in 2026. Ada Health is the direct AI symptom-checker heir with CE marking, 140-country coverage, and peer-reviewed clinical evidence, K Health is the closest US virtual primary care match at $29 per month, Healthily is the free UK self-care companion, Buoy Health is the US symptom-to-care navigator, Teladoc Health and Amwell dominate insured US telehealth, Doctolib leads EU and UK booking with video, and Infermedica is the clinician-facing triage API used by hospitals and payers worldwide. These eight tools like Babylon Health, grouped by AI symptom check, virtual primary care, and clinician-facing triage and ranked with a rise-and-fall timeline, per-tool pricing, capability matrix, decision tree, and migration playbook, cover every reason a Babylon user is searching for a new home in 2026.

πŸͺ¦ Other dead Chatbot tools

❓ Frequently Asked Questions

Is Babylon Health still operating?

No. The US arm filed Chapter 7 in August 2023 and the UK arm went into administration the same year. All apps were withdrawn.

What happened to my Babylon records?

UK NHS contracts were transferred to other GP federations. Private records were addressed through bankruptcy estate procedures.

Was the AI doctor accurate?

UK regulators flagged accuracy and safety concerns repeatedly. Independent audits suggested it lagged human triage on serious conditions.

Why did Babylon fail?

Overbuilt cost base, weak unit economics on NHS contracts, an underperforming SPAC, and an AI product that did not deliver on marketing claims.